Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk's patent on its branded drugs Ozempic and Wegovy is set to expire in January. "Canada is a major opportunity to show what affordable, high-quality weight loss care can look like," said Andrew Dudum,…